| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.056 | 0.4 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |